Quarter Financials
Altimmune, Inc. (ALT)
$14.1
+0.19 (+1.37%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
|---|
| Net Income | -24 | -20 | -19 | 73 | -34 | -25 | -15 | -11 |
|---|
| Dividend Paid | - | - | - | - | - | - | - | - |
|---|
| Retained Earnings | -356 | -333 | -313 | -293 | -269 | -236 | -211 | -186 |
|---|
|
Year
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
|---|
| Capital Expenditure | -0 | -0 | -0 | - | -0 | -8 | -4 | -0 |
|---|
| Net PPE | 1 | 1 | 1 | 1 | 5 | 5 | 6 | 2 |
|---|
|
Year
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
|---|
| New Purchases | -54 | -7 | 0 | -0 | - | - | -49 | -25 |
|---|
| Intangible and Goodwill | - | - | - | - | - | - | - | - |
|---|